We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+26.05%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62.3B
AUM Growth
+$13.8B
Cap. Flow
+$3.01B
Cap. Flow %
4.83%
Top 10 Hldgs %
42.27%
Holding
775
New
54
Increased
269
Reduced
324
Closed
89

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$751M
2
PG icon
Procter & Gamble
PG
+$623M
3
NVO
Novo Nordisk
NVO
+$579M
4
MRK icon
Merck
MRK
+$440M
5
YUMC icon
Yum China
YUMC
+$153M

Sector Composition

Rank Sector Weight
1 Technology 26.89%
2 Consumer Discretionary 16.68%
3 Healthcare 12.96%
4 Communication Services 12.75%
5 Financials 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BR icon
201
Broadridge
BR
$19B
$21.4M 0.03%
169,303
+13,108
+8% +$1.52M
WEN icon
202
Wendy's
WEN
$1.46B
$21.3M 0.03%
976,747
+74,660
+8% +$1.48M
MKTX icon
203
MarketAxess Holdings
MKTX
$5.72B
$21M 0.03%
41,935
-9,183
-18% -$4.28M
IAA
204
DELISTED
IAA, Inc. Common Stock
IAA
$21M 0.03%
543,570
-29,384
-5% -$1.1M
XNCR icon
205
Xencor
XNCR
$1.55B
$20.8M 0.03%
641,976
+55,871
+10% +$1.71M
TRMB icon
206
Trimble
TRMB
$13.9B
$20.8M 0.03%
480,626
+37,262
+8% +$1.4M
XIFR
207
XPLR Infrastructure LP
XIFR
$1.08B
$20.7M 0.03%
404,454
-15,464
-4% -$749K
CRL icon
208
Charles River Laboratories
CRL
$12.8B
$20.6M 0.03%
118,229
+9,068
+8% +$1.45M
HOMB icon
209
Home BancShares
HOMB
$6.18B
$20.5M 0.03%
1,332,434
-45,434
-3% -$638K
GRA
210
DELISTED
W.R. Grace & Co.
GRA
$20.5M 0.03%
403,232
+2,769
+0.7% +$131K
RCKT icon
211
Rocket Pharmaceuticals
RCKT
$394M
$20.2M 0.03%
+965,584
New +$17.4M
BPOP icon
212
Popular Inc
BPOP
$11.1B
$20.1M 0.03%
540,536
+38,176
+8% +$1.42M
CHE icon
213
Chemed
CHE
$7.22B
$20M 0.03%
44,291
+3,403
+8% +$1.52M
ROG icon
214
Rogers Corp
ROG
$2.4B
$19.7M 0.03%
158,053
+13,531
+9% +$1.45M
SKX
215
DELISTED
Skechers
SKX
$19.5M 0.03%
+622,895
New +$17.9M
ARGX icon
216
argenx
ARGX
$54.1B
$19.5M 0.03%
86,579
-184,579
-68% -$32.8M
CYRX icon
217
CryoPort
CYRX
$762M
$19.1M 0.03%
+631,609
New +$14.1M
EEFT icon
218
Euronet Worldwide
EEFT
$2.7B
$18.9M 0.03%
197,399
-7,129
-3% -$658K
ASND icon
219
Ascendis Pharma A/S
ASND
$16.8B
$18.7M 0.03%
126,390
+9,795
+8% +$1.34M
PATK icon
220
Patrick Industries
PATK
$2.85B
$18.7M 0.03%
+457,391
New +$13.9M
DRNA
221
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$18.4M 0.03%
+725,003
New +$15.6M
HEI icon
222
HEICO Corp
HEI
$51.4B
$18.4M 0.03%
184,613
+14,125
+8% +$1.3M
AVLR
223
DELISTED
Avalara, Inc.
AVLR
$18.4M 0.03%
138,133
+10,640
+8% +$1.05M
ESE icon
224
ESCO Technologies
ESE
$7.92B
$18.1M 0.03%
213,779
+16,410
+8% +$1.3M
SHOO icon
225
Steven Madden
SHOO
$3.55B
$18M 0.03%
729,668
+63,477
+10% +$1.48M

Similar funds

Loomis, Sayles & Company's Q2 2020 Portfolio in Review

As of Q2 2020, Loomis, Sayles & Company held 775 positions worth $62.3B, up 28% from $48.5B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Loomis, Sayles & Company deployed $3.01B of net new capital in Q2 2020, opening 54 new positions and adding to 269 existing holdings. Its largest new stake was Dropbox: 3,912,402 shares worth $85.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $751M trimmed.

  • Loomis, Sayles & Company's largest Q2 2020 buy was Dropbox: 3,912,402 shares worth $85.2M.
  • Loomis, Sayles & Company added most to Bank of America Series L in Q2 2020, an estimated $1.47B increase.
  • Loomis, Sayles & Company's biggest Q2 2020 reduction was Amgen, cutting an estimated $751M.
  • Loomis, Sayles & Company fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q2 2020, selling an estimated $32.2M.
  • Loomis, Sayles & Company's ten largest holdings make up 42% of its $62.3B portfolio in Q2 2020.
  • Loomis, Sayles & Company opened 54 new positions and closed 89 in Q2 2020.
  • Loomis, Sayles & Company's portfolio value rose 28% quarter-over-quarter to $62.3B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2020, filed 14 Aug 2020.